Encapsulation & Immunoprotective Strategies of Islet Cells
Washington, DC
December 6-7, 2001
Sponsored by
Juvenile Diabetes Research Foundation International
National Aeronautics and Space Administration
National Istitute of Diabetes and Digestive and Kidney Diseases
National Center for Research Resources
Summary
For nearly 20 years, research on encapsulating transplanted islet cells as a means of preventing rejection by the body’s immune system has seen little progress. However, with isolated reports of success in a few experiments, the promise remains.
On December 6-7, 2001, more than 60 leading scientists from eight countries and other key individuals participated in a workshop to review the current state of encapsulation technology and to develop a strategy for the best use of a $2 million appropriation that the National Aeronautics and Space Administration will be directing toward research in this area.
Held near Washington, DC, the workshop included presentations from scientists on the latest technology, advances, and results in the field of encapsulation. Sessions were divided into four key areas: encapsulation and immunobarriers, industry perspectives, immunoprotective and anti-inflammatory therapies, and gene therapy for islet immunoprotection.
Page last updated: May 05, 2008
